Revolution Medicines $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
AC Immune $80 million at-the-market offering
We advised AC Immune on the offering
Adecoagro cash tender offer
We advised the company on the tender offer
Southwest Gas Holdings $340 million at-the-market offering
The shares are listed on the New York Stock Exchange
Emera $1.252 billion sale of its New Mexico gas utility business
We are advising Emera on the transaction
SGH $175 million convertible notes offering and capped call transactions
The 2% convertible senior notes are due 2030
MicroStrategy $2 billion at-the-market offering
The stock is listed on the Nasdaq Global Select Market
Banco Santander $1.5 billion Tier 1 capital securities offering
We advised Banco Santander on its SEC-registered offering of contingent convertible securities
Synchrony Financial $750 million senior notes offering
The investment-grade notes are due 2030
Eastman Chemical $500 million notes offering and concurrent cash tender offer
The investment-grade notes are due 2029